The Patent Finder

Magnesium Diagnostics, Inc.

Also on record
Records under this name other than patents Magnesium Diagnostics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Magnesium Diagnostics, Inc.

PatentTitleStatus Expires Confidence
US 6,372,440Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
Formerly held
Term ended
Term ended Mar 10, 2019 · From the USPTO record
Term endedTerm ended Mar 10, 2019From the USPTO record
US 8,129,545Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended Mar 6, 2016 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2016From the USPTO record
US 6,664,420Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended Dec 16, 2015 · From the USPTO record
Lapsed on the fee recordEnded Dec 16, 2015From the USPTO record
US 7,982,048Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended Jul 19, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jul 19, 2015From the USPTO record
US 7,211,667Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended May 1, 2015 · From the USPTO record
Lapsed on the fee recordEnded May 1, 2015From the USPTO record
US 7,132,537Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended Nov 7, 2014 · From the USPTO record
Lapsed on the fee recordEnded Nov 7, 2014From the USPTO record
US 6,455,734Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended Sep 24, 2014 · From the USPTO record
Lapsed on the fee recordEnded Sep 24, 2014From the USPTO record
US 7,795,450Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended Sep 14, 2014 · From the USPTO record
Lapsed on the fee recordEnded Sep 14, 2014From the USPTO record
US 7,041,829Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended May 9, 2014 · From the USPTO record
Lapsed on the fee recordEnded May 9, 2014From the USPTO record
US 7,619,097Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Lapsed on the fee record
Ended Nov 17, 2013 · From the USPTO record
Lapsed on the fee recordEnded Nov 17, 2013From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited